Clinical review: Drotrecogin alfa (activated) as adjunctive therapy for severe sepsis – practical aspects at the bedside and patient identification

This publication has 17 references indexed in Scilit:

• Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis
  Critical Care Medicine, 2003
• Pharmacokinetic‐pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis
  Clinical Pharmacology & Therapeutics, 2002
• Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway
  Science, 2002
• High-Dose Antithrombin III in Severe Sepsis
  JAMA, 2001
• The risk of stroke and death in patients with aortic and mitral valve endocarditis
  American Heart Journal, 2001
• Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis
  Journal of Biological Chemistry, 2001
• Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
  New England Journal of Medicine, 2001
• Neurologic Manifestations of Infective Endocarditis
  Archives of internal medicine (1960), 2000
• The protein C anticoagulant pathway.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• APACHE II
  Critical Care Medicine, 1985